Laurus Labs acquires stake in Indian CAR-T therapy developer ImmunoACT

Laurus Labs said that it has acquired a stake of 26.62% in Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an Indian cell and gene therapy company ... Read More